| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $4,221,816 ) |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01ES036051 | circSATB2, a novel regulator of arsenic-induced carcinogenesis | 000 | 3 | NIH | 12/16/2025 | $632,177 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM145378 | Mechanisms of mutant mitochondrial genome modulation | 002 | 6 | NIH | 1/21/2026 | $432,000 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R25HG011020 | Epigenomics Workshop for Graduate Students | 000 | 5 | NIH | 12/15/2025 | $51,777 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01MH139201 | The immunobiological mechanisms of depression in perimenopause | 000 | 2 | NIH | 1/16/2026 | $765,613 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM152081 | Mechanisms and Applications of RNA-mediated Enzymes in Translation and Immunity | 000 | 4 | NIH | 1/30/2026 | $563,163 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01ES034253 | Molecular mechanisms of iAs-mediated carcinogenesis through the lens of histone H2B variants | 000 | 5 | NIH | 2/11/2026 | $666,885 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01CA276031 | Mechanisms of cancer mutations | 000 | 4 | NIH | 12/10/2025 | $434,294 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AI165580 | Elucidating the Structural Mechanisms of NAIP Receptors in Bacterial Detection and Inflammasome Activation | 000 | 5 | NIH | 12/29/2025 | $480,000 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM145378 | Mechanisms of mutant mitochondrial genome modulation | 001 | 5 | NIH | 12/18/2025 | $315,817 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AR079174 | 5-methylcytosine oxidation in development and disease | 000 | 5 | NIH | 1/9/2026 | $0 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01CA268440 | High Throughput Screen for Inhibitors of the YEATS2 Histone Acylation Reader | 000 | 4 | NIH | 12/4/2025 | $0 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | K99CA286742 | The role of AHR in modulatingimmunotherapy response and adverse events in bladder cancer | 000 | 2 | NIH | 11/24/2025 | $0 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F99CA305570 | Targeting mechanisms of chromatin plasticity to improve the efficacy of epigenetic solid tumor therapy | 000 | 1 | NIH | 12/10/2025 | $0 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F99CA294248 | Determinants of susceptibility to pediatric acute myeloid leukemia | 000 | 2 | NIH | 11/26/2025 | $0 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F31NS139616 | Cortical Neuronal Vulnerability in Parkinson's Disease | 000 | 1 | NIH | 11/17/2025 | -$21,887 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F30CA268840 | A Molecular Case Series: Deep Cellular and Spatial Epigenetic Characterization of Human Colorectal Cancer | 000 | 3 | NIH | 1/7/2026 | -$54,537 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F31AG084199 | Identifying Determinants of Tau Pathology Seeding | 000 | 2 | NIH | 1/16/2026 | -$27,061 |
| | 2026 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R56ES034765 | Molecular mechanisms underlying metabolic reprogramming by paternal benzene exposure | 000 | 1 | NIH | 2/13/2026 | $0 |
| | 2026 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R37CA230748 | High-throughput Epigenomic Mapping of Regulatory Elements in Ovarian Cancer at Basepair Resolution | 000 | 7 | NIH | 11/24/2025 | -$16,425 |
| | 2026 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R00CA255928 | Understanding the effects of dietary interventions on pancreatic ductal adenocarcinoma therapy cancer | 000 | 4 | NIH | 1/14/2026 | $0 |
| | 2026 | 2023 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01CA234595 | DNA hypermethylation in lung tumors | 000 | 5 | NIH | 1/14/2026 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $25,339,232 ) (Continued on the next page) |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | K99CA293261 | Targeting PTGIR-Prostacyclin Signaling to Overcome T Cell Exhaustion and Enhance Anti-Tumor Immunity | 000 | 1 | NIH | 7/30/2025 | $112,234 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01CA269394 | Harnessing the therapeutic potential of histotripsy focused ultrasound-induced immunogenic cancer cell death | 003 | 4 | NIH | 5/20/2025 | $496,811 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | U01CA297713 | Dietary regulation of anti-tumor immunity through caloric restriction | 000 | 1 | NIH | 3/17/2025 | $767,324 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01ES034253 | Molecular mechanisms of iAs-mediated carcinogenesis through the lens of histone H2B variants | 000 | 4 | NIH | 3/4/2025 | $655,853 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM152184 | Molecular mechanisms of chromatin signaling and epigenetic regulation | 001 | 2 | NIH | 5/2/2025 | $518,400 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F30GM154476 | Upstream Requirements for the Regulation of Mitochondrial Bioenergetics by the Mitochondrial Acyl Carrier Protein | 001 | 2 | NIH | 5/22/2025 | $564 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F99CA294248 | Determinants of susceptibility to pediatric acute myeloid leukemia | 000 | 1 | NIH | 12/6/2024 | $3,000 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F30GM154476 | Upstream Requirements for the Regulation of Mitochondrial Bioenergetics by the Mitochondrial Acyl Carrier Protein | 000 | 2 | NIH | 5/14/2025 | $47,974 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F99CA294248 | Determinants of susceptibility to pediatric acute myeloid leukemia | 002 | 2 | NIH | 9/10/2025 | $0 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F99CA294248 | Determinants of susceptibility to pediatric acute myeloid leukemia | 001 | 2 | NIH | 8/15/2025 | $51,538 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | U24CA264023 | Integrative Cancer Epigenomic Data Analysis Center (ICE-DAC) | 000 | 5 | NIH | 9/3/2025 | $456,000 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | U01CA286580 | Diet-mediated regulation of fatty acid saturation impacts cancer progression and therapy responses. | 001 | 2 | NIH | 5/28/2025 | $79,679 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | U01CA286580 | Diet-mediated regulation of fatty acid saturation impacts cancer progression and therapy responses. | 000 | 2 | NIH | 3/26/2025 | $717,119 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AI165580 | Elucidating the Structural Mechanisms of NAIP Receptors in Bacterial Detection and Inflammasome Activation | 001 | 4 | NIH | 11/5/2024 | $465,600 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01ES036051 | circSATB2, a novel regulator of arsenic-induced carcinogenesis | 000 | 2 | NIH | 11/5/2024 | $628,913 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R25HG011020 | Epigenomics Workshop for Graduate Students | 000 | 4 | NIH | 11/6/2024 | $51,777 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM152081 | Mechanisms and Applications of RNA-mediated Enzymes in Translation and Immunity | 002 | 3 | NIH | 8/5/2025 | $62,573 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM152081 | Mechanisms and Applications of RNA-mediated Enzymes in Translation and Immunity | 000 | 3 | NIH | 1/17/2025 | $563,163 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F31AG084199 | Identifying Determinants of Tau Pathology Seeding | 000 | 2 | NIH | 6/25/2025 | $48,538 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AG084743 | Accelerated DNA Methylation Alterations in Hutchinson-Gilford Progeria Syndrome | 001 | 3 | NIH | 6/20/2025 | $62,896 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AG084743 | Accelerated DNA Methylation Alterations in Hutchinson-Gilford Progeria Syndrome | 000 | 3 | NIH | 4/30/2025 | $707,577 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AG083568 | Endogenous retrovirus in joint aging and osteoarthritis development | 001 | 3 | NIH | 6/20/2025 | $46,822 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AG083568 | Endogenous retrovirus in joint aging and osteoarthritis development | 000 | 3 | NIH | 4/18/2025 | $526,751 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01DK139630 | Understanding putative beta-cell subtypes | 000 | 2 | NIH | 8/18/2025 | $675,646 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AG077573 | Network and cellular vulnerability to pathological protein progression | 001 | 4 | NIH | 6/10/2025 | $35,292 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AG077573 | Network and cellular vulnerability to pathological protein progression | 000 | 4 | NIH | 5/9/2025 | $397,041 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM147261 | Epigenetic Mechanisms of Retrotransposon Silencing | 000 | 4 | NIH | 7/7/2025 | $475,000 |
|
